Background: Using fluorescently labeled superoxide dismutase (SOD) and now
cytometry, we have shown previously that the enzyme CuZn SOD (EC 1.15.1.1)
from bovine erythrocytes binds rapidly to the cell surface with slow uptake
into the cell during the following hours. The degree of labeling was most
important for monocytes in comparison to other blood cells (erythrocytes, l
ymphocytes, and neutrophils) and fibroblasts. In agreement with the flow-cy
tometric findings, the inhibition of superoxide production was more importa
nt for SOD-pretreated monocytes than for neutrophils, as demonstrated with
the cytochrome c reduction assay. It was thus of interest to confirm the ob
served differences between monocytes and neutrophils with confocal laser mi
croscopy, study in greater detail the kinetics of binding penetration, and
intracellular localization of the enzyme, and compare the results obtained
with bovine CuZn SOD with those from SODs of other origins and carrying dif
ferent active sites.
Materials and Methods: Recombinant human (rh), bovine, and equine CuZn SODs
, as well as rh and E. coli Mn SODs, were studied before use with respect t
o specific activity and purity (HPLC, SDS-PAGE electrophoresis). Fluorescei
n isothiocyanate was covalently conjugated to the various SODs for study wi
th high-resolution confocal scanning laser microscopy. Superoxide productio
n by monocytes and neutrophils was measured with the cytochrome c assay.
Results: As expected from our experiments with flow cytometry, only rare ne
utrophils were labeled with FITC-SOD, even with the longest incubation time
of 3 hr and the highest dose of 1500 units/ml. In addition, they showed a
localized fluorescence pattern that was quite different from the diffuse pu
nctate fluorescence pattern of monocytes. Lymphocytes were not labeled at a
ll. The rapid binding to the cellular surface of monocytes was confirmed an
d even after 5 min of preincubation, FITC-SOD was found on a small percenta
ge of monocytes. This was correlated with a reduction in superoxide release
after phorbolmyristate acetate (PMA) stimulation by 40%. An interesting fi
nding was the perinuclear accumulation of the penetrated SOD after the long
est pretreatment of 3 hr, suggesting a barrier against further progression.
Indeed, through confocal microscopy we were able to exclude any fluorescen
ce at the nuclear level. While the fluorescence labeling patterns and the k
inetics of penetration were quite similar for bovine, equine, and rh CuZn S
OD, the Mn SODs showed poor labeling, correlated with a weak inhibitory eff
ect on cytochrome c reduction which was not statistically significant.
Conclusions: The rapid binding of native CuZn SODs on the surface of monocy
tes, leading to reduced superoxide release by these cells, explains the obs
ervation that beneficial effects of injected SOD lasted for months despite
rapid clearance of the enzyme from the bloodstream, according to pharmacody
namic studies. The preferential binding to monocytes, in contrast to neutro
phils, may play a role in chronic inflammatory diseases in which the monocy
tes are in an activated state. The differences in binding capacity between
CuZn SODs and Mn SODs, correlated with different inhibitory effects of supe
roxide production by monocytes, may also have therapeutic significance.